Buscar
Mostrando ítems 31-40 de 1045
Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission
(ELSEVIER SCIENCE BV, 2008)
Rats with unilateral lesion of the substantia nigra pars compacta (SNpc) have been used as a model of Parkinson`s disease. Depending on the lesion protocol and on the drug challenge, these rats rotate in opposite directions. ...
Involvement of dopamine receptors in diethylpropion-induced conditioning place preference
(Associação Brasileira de Divulgação Científica (ABRADIC), 1998-04-01)
Diethylpropion (DEP) is an amphetamine-like agent used as an anorectic drug. Abuse of DEP has been reported and some restrictions of its use have been recently imposed. The conditioning place preference (CPP) paradigm was ...
Involvement of dopamine receptors in diethylpropion-induced conditioning place preference
(Associação Brasileira de Divulgação Científica (ABRADIC), 1998-04-01)
Diethylpropion (DEP) is an amphetamine-like agent used as an anorectic drug. Abuse of DEP has been reported and some restrictions of its use have been recently imposed. The conditioning place preference (CPP) paradigm was ...
Endogenous opioids mediate basal hedonic tone independent of dopamine d-1 or d-2 receptor activation
(Pergamon-Elsevier Science Ltd, 2004-01)
Exogenously administered opiates are recognized as rewarding and the involvement of dopamine systems in mediating their apparent pleasurable effects is contentious. The aversive response to naloxone administration observed ...
Involvement of dopamine receptors in diethylpropion-induced conditioning place preference
(Associação Brasileira de Divulgação Científica (ABRADIC), 2014)
Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates
(Wiley-Blackwell, 2013-10-01)
The objective of the present study was to further elucidate the mechanisms involved in the wake-promoting effects of psychomotor-stimulants. Many previous studies have tightly linked the effects of stimulants to dopamine ...